| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers N > Headlines for Norwood Immunology Ltd. > News item |
Norwood signs research agreement with Australian stem cell center, university
By Elaine Rigoli
Tampa, Fla., March 21 - Norwood Immunology Ltd. has signed a tripartite research agreement with the Australian Stem Cell Centre (ASCC) and Monash University to form a new technology platform combining immune system research with stem cell knowledge.
The new research technology has the potential to add significant value to Norwood's and ASCC's intellectual property pipelines, according to a company news release.
The research will focus on controlling the immune system to minimize rejection of stem-cell therapies introduced into the body, the release said.
The research will be funded jointly by the ASCC and Norwood and the intellectual property that results from the work will be jointly owned, the release said.
Under the agreement, Norwood will provide the ASCC with access to its thymic and bone marrow regrowth technology. This provides a method of replenishing stem cells and potentially facilitates the engraftment and uptake of introduced stem cells into the body, improving their ability to repair damaged tissue and minimizing their likelihood of rejection.
"The research skills of Norwood Immunology and the ASCC are highly complementary and the incorporation of stem cells should also enhance Norwood Immunology's platform technology for repairing damage to the immune system. I believe we are the only group with a research program that aims to combine the immune system with stem-cell technology," Richard Boyd, chief scientific officer and director of the research program, said in the release.
Norwood, based in Victoria, Australia, focuses on technologies and therapies to rejuvenate activity of the immune system.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.